Khalid Jazieh

ADAM10 and ADAM17 cleave PD-L1 to mediate PD-(L)1 inhibitor resistance

Jacob J. Orme, Khalid Jazieh, Tiancheng Xie et al. · OncoImmunology · 2020 · 126 citations · Full text

Medicine, Cancer Biology, Oncology +17

Epidemiology of Cholangiocarcinoma; United States Incidence and Mortality Trends

Mohamed M. Gad, Anas M. Saad, Mohammed Faisaluddin et al. · Clinics and Research in Hepatology and Gastroenterology · 2020 · 91 citations

Medicine, Oncology, Pathology +13

Novel imaging biomarkers predict outcomes in stage III unresectable non-small cell lung cancer treated with chemoradiation and durvalumab

Khalid Jazieh, Mohammadhadi Khorrami, Anas M. Saad et al. · Journal for ImmunoTherapy of Cancer · 2022 · 56 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Tumor PD-L1 expression is associated with outcomes in stage III non-small cell lung cancer (NSCLC) patients treated with consolidation durvalumab

Khalid Jazieh, Mohamed M. Gad, Anas M. Saad et al. · Translational Lung Cancer Research · 2021 · 22 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Outcome disparities in colorectal cancer: a SEER-based comparative analysis of racial subgroups

Muneer J. Al‐Husseini, Anas M. Saad, Khalid Jazieh et al. · International Journal of Colorectal Disease · 2018 · 20 citations

Public Health, Biostatistics, Oncology +17